ADVANCED BIOMED INC (ADVB) Stock Price & Overview

NASDAQ:ADVB • US00752P2039

Current stock price

4.19 USD
0 (0%)
Last:

The current stock price of ADVB is 4.19 USD. Today ADVB is down by 0%. In the past month the price increased by 4.49%. In the past year, price decreased by -94.76%.

ADVB Key Statistics

52-Week Range3.61 - 80
Current ADVB stock price positioned within its 52-week range.
1-Month Range3.6659 - 5.82
Current ADVB stock price positioned within its 1-month range.
Market Cap
5.698M
P/E
1.06
Fwd P/E
N/A
EPS (TTM)
3.97
Dividend Yield
N/A

ADVB Stock Performance

Today
0%
1 Week
-0.12%
1 Month
+4.49%
3 Months
-42.85%
Longer-term
6 Months -53.01%
1 Year -94.76%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

ADVB Stock Chart

ADVANCED BIOMED INC / ADVB Daily stock chart

ADVB Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ADVB. When comparing the yearly performance of all stocks, ADVB is a bad performer in the overall market: 97.83% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ADVB Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ADVB. ADVB has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ADVB Earnings

Next Earnings DateMay 13, 2026
Last Earnings DateFeb 13, 2026
PeriodQ2 / 2026
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

ADVB Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

ADVB Groups

Sector & Classification

Index Membership

ADVB Financial Highlights

Over the last trailing twelve months ADVB reported a non-GAAP Earnings per Share(EPS) of 3.97. The EPS decreased by -23.49% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)4.39M
Industry RankSector Rank
PM (TTM) N/A
ROA 40.42%
ROE 46.25%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%803.33%
Sales Q2Q%N/A
EPS 1Y (TTM)-23.49%
Revenue 1Y (TTM)N/A

ADVB Ownership

Ownership
Inst Owners0.16%
Shares1.36M
Float610.00K
Ins Owners47.05%
Short Float %N/A
Short Ratio0.07

ADVB Latest News, Press Relases and Analysis

About ADVB

Company Profile

ADVB logo image Advanced Biomed Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Reno, Nevada and currently employs 31 full-time employees. The company went IPO on 2025-03-06. Advanced Biomed Inc. is a holding company that operates, through its subsidiary, Advanced Biomed Inc. (Taiwan). The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

Company Info

IPO: 2025-03-06

ADVANCED BIOMED INC

401 Ryland St, Ste 200-A

Reno NEVADA US

Employees: 31

ADVB Company Website

ADVB Investor Relations

Phone: 1862120510823

ADVANCED BIOMED INC / ADVB FAQ

Can you describe the business of ADVANCED BIOMED INC?

Advanced Biomed Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Reno, Nevada and currently employs 31 full-time employees. The company went IPO on 2025-03-06. Advanced Biomed Inc. is a holding company that operates, through its subsidiary, Advanced Biomed Inc. (Taiwan). The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.


What is the current price of ADVB stock?

The current stock price of ADVB is 4.19 USD.


What is the dividend status of ADVANCED BIOMED INC?

ADVB does not pay a dividend.


How is the ChartMill rating for ADVANCED BIOMED INC?

ADVB has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


On which exchange is ADVB stock listed?

ADVB stock is listed on the Nasdaq exchange.


What is the GICS sector and industry of ADVB stock?

ADVANCED BIOMED INC (ADVB) operates in the Health Care sector and the Health Care Equipment & Supplies industry.